Companies › PLX

PROTALIX BIOTHERAPEUTICS INC (PLX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001006281 · EDGAR filings · Updated 2026-06-25

PROTALIX BIOTHERAPEUTICS INC (PLX) has reported institutional ownership of 20.7%, with 99 institutional managers holding positions valued at $36.1M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-06-25 — Current report (8-K) filed
• 2026-05-21 — Current report (8-K) filed
• 2026-05-13 — Quarterly report (10-Q) filed
• 2026-05-13 — Current report (8-K) filed
• 2026-04-30 — ARS filed
• 2026-04-30 — Proxy statement (DEF 14A) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, PROTALIX BIOTHERAPEUTICS INC has 99 institutional holders and institutional ownership of 20.7%.

Insider activity

Insiders reported 12 transactions (2 buys, 1 sells) across 9 reporting insiders, with a net reported value of $307.4K.

Data flags from SEC filings

Related companies

BIOMEA FUSION INC (BMEA) · INSPIREMD INC (NSPR) · iBio Inc (IBIO) · SEER INC (SEER) · HUMACYTE INC (HUMA) · NUVECTIS PHARMA INC (NVCT)